Crossing barriers: the burden of inflammatory bowel disease across Western Europe
An estimated 2.5–3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently resulting in a significant cost to the healthcare system of an estimated 4.6–5.6 billion e...
Main Authors: | Aditi Kumar, Nuha Yassin, Alexandra Marley, Vittoria Bellato, Caterina Foppa, Gianluca Pellino, Pär Myrelid, Monica Millan, Beatriz Gros, Nicolas Avellaneda, Ignacio Catalan-Serra, Alaa El-Hussuna, João A. Cunha Neves, Joana Roseira, Miguel F. Cunha, Bram Verstockt, Dominik Bettenworth, Diane Mege, Matthew J. Brookes |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848231218615 |
Similar Items
-
Genetic influences on the development of fibrosis in Crohn’s Disease
by: Bram eVerstockt, et al.
Published: (2016-05-01) -
Surgical Planning in Penetrating Abdominal Crohn's Disease
by: Pär Myrelid, et al.
Published: (2022-05-01) -
Are anthropometric characteristics powerful markers to predict the Cooper Run Test? Actual Caucasian data
by: Gianluca Azzali, et al.
Published: (2023-04-01) -
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
by: Dahham Alsoud, et al.
Published: (2022-01-01) -
„Innen“ und „Außen“ bei Herondas
by: Anja Bettenworth
Published: (2021-08-01)